Shreegen Pharma Limited - Company Profile

It is a pharma public limited company based in Ameerpet, Telangana, India, established in 2012.
2012 Ameerpet, Telangana, India Active
Last Updated:
Access Report
About Shreegen Pharma Limited

Shreegen Pharma Limited, a active public limited company, was established on 18 October 2012 in Ameerpet, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24233TG2012PLC083695. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹25.00 Cr.

Formerly known as Shree Gen Pharma Limited. It upholds a compliant status. Employing 26 professional, Its leadership includes Rama Mangeswar Reddy Bobbiti (Managing Director), Kanaka Nallamilli Sundara Reddy (Director), Chandra Balireddy Kotthapalli (Additional Director). Past directors included Rama Mangeswar Reddy Bobbiti, Naveen Kumar Kotla, Bobbiti Venkata Rami Reddy. It holds ₹11.69 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Hno. 7-1-638 To 643 Flat 305, Bhanu Enclave, Beside Esi Hospital, Sundernagar,Erragadda, Ameerpet, Telangana, 500038.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233TG2012PLC083695

  • Registration Number

    083695

  • Incorporation Date

    18 October 2012

  • Authorized Capital

    ₹25.00 Cr

  • Paid-Up Capital

    ₹25.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 25.00 Cr
  • Paid Up Capital ₹ 25.00 Cr
  • Company Age 13 Year, 6 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 11.69 Cr
  • Revenue Growth **** -52.92%
  • Profit Growth **** -6104.85%
  • Ebitda **** -197.75%
  • Net Worth -62.59%
  • Total Assets -6.91%
Company report

Shreegen Pharma Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Shreegen Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Shreegen Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Rama Mangeswar Reddy Bobbiti Managing Director 18 Oct 2012 Current
Kanaka Nallamilli Sundara Reddy Director 30 Sep 2016 Current
Chandra Balireddy Kotthapalli Additional Director 14 May 2025 Current
Srinivasa Reddy Daka Director 18 Oct 2012 Current
Rajeev Dinesh Srivastava Additional Director 14 May 2025 Current
Sishtla Ramakrishnan Director 01 Aug 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Oct 2016 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Director 25 Mar 2014 Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past
Pramod Abcsdd Director 16 Feb 2019 Past
Pramod Abcsdd Cfo - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Shreegen Pharma.

Shreegen Pharma Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 52.92% decrease. The company also saw a substantial fall in profitability, with a 6104.85% decrease in profit. The company's net worth observed a substantial decline by a decrease of 62.59%.

Shreegen Pharma revenue growth over time
Shreegen Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -52.92%
*******
*******
*******
*******
Revenue from Operations
*******
 -51.73%
*******
*******
*******
*******
Total Assets
*******
 -6.91%
*******
*******
*******
*******
Profit or Loss
*******
 -6104.85%
*******
*******
*******
*******
Net Worth
*******
 -62.59%
*******
*******
*******
*******
EBITDA
*******
 -197.75%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Shreegen Pharma?

In 2020, Shreegen Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹116,900,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 11.69 Cr
Latest Charge Details
Date Lender Amount Status
13 Apr 2015 State Bank Of India ₹11.69 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Shreegen Pharma?

Shreegen Pharma has a workforce of 26 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Shreegen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shreegen Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Shreegen Pharma
Recent Activity within the Organization
  • Director Appointment

    Sishtla Ramakrishnan was appointed as a Director was appointed as a Director on 01 Aug 2025 & has been associated with this company since 8 months 16 days . was recorded as a recent event.

  • Director Appointment

    Progress on Chandra Balireddy Kotthapalli was appointed as a Additional Director was appointed as a Additional Director on 14 May 2025 & has been associated with this company since 11 months 4 days . was documented.

  • Director Appointment

    Progress on Rajeev Dinesh Srivastava was appointed as a Additional Director was appointed as a Additional Director on 14 May 2025 & has been associated with this company since 11 months 4 days . was documented.

  • Annual General Meeting

    The activity Shreegen Pharma Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.

  • Balance Sheet

    Shreegen Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was recorded as a recent event.

  • Charges

    Progress on A charge with State Bank Of India of Rs. 11.69 Cr registered on 13 Apr 2015 with Charge ID 10569557 was modified on 29 Sep 2021. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Shreegen Pharma Limited?

The CIN of Shreegen Pharma Limited is U24233TG2012PLC083695.

Where is Shreegen Pharma Limited headquartered?

Shreegen Pharma Limited is headquartered at Hno. 7-1-638 To 643 Flat 305, Bhanu Enclave, Beside Esi Hospital, Sundernagar,Erragadda, Ameerpet, Telangana, 500038.

When was Shreegen Pharma Limited incorporated?

Shreegen Pharma Limited was incorporated on 18 October 2012.

Who are the current directors of Shreegen Pharma Limited?

The current directors of Shreegen Pharma Limited are

What is the primary industry of Shreegen Pharma Limited?

The primary industry of Shreegen Pharma Limited is Manufacturing.

Is Shreegen Pharma Limited a listed company?

Shreegen Pharma Limited is unlisted.

What is the capital structure of Shreegen Pharma Limited?

The authorized capital of Shreegen Pharma Limited is ₹25.00 Cr, and the paid-up capital is ₹25.00 Cr.

What is the compliance status of Shreegen Pharma Limited?

The compliance status of Shreegen Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available